Transactions announcement

Managers' transactions announcement according to article 19 MAR

 

Paiania, 12 May 2023 – Lavipharm S.A., according to the provisions of article 19 of the European Regulation No 596/2014 and following relevant notification, announces that Mr. Thomas Tseronis, Head of Sales Rx, sold 35.434 Lavipharm common shares, amounting in total to Euro 15.732,7.

###

Admission of new shares resulting from share capital increase following the exercise of stock options (Stock Option Plan)

The Société Anonyme under the name "FLEXOPACK SOCIÉTÉ ANONYME COMMERCIAL AND INDUSTRIAL PLASTICS COMPANY” and the distinctive title “FLEXOPACK S.A.”  (hereinafter referred to as the "Company"), announces that on the 18th of May 2023, commences the trading in the Athens Stock Exchange of 74,200 new, common, regist

Subscribe to May